circROBO1通过加速糖解促进前列腺癌生长和通过加速糖解促进酶胺耐药性
Zhigang Zhou1,2, Jing Qin2, Cailu Song3
1Research Center of Cancer Diagnosis and Therapy, Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China.
Journal of Cancer
|September 6, 2023
概括
循环RNAs (circRNAs) 通过加速糖分解来驱动前列腺癌的生长和酶胺耐药性. 针对circROBO1-miR-556-5p-PGK1轴为前列腺癌提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 循环RNAs (circRNAs) 是涉及癌症进展的非编码RNA.
- 在前列腺癌中circRNAs的特定作用仍然在很大程度上未被描述.
- 了解circRNA功能对于开发新型癌症疗法至关重要.
研究的目的:
- 调查circRNAs在前列腺癌进展和胺胺耐药性的作用.
- 识别新型circRNA并阐明它们在前列腺癌中的分子机制.
- 探索前列腺癌治疗的潜在治疗点.
主要方法:
- 功能丧失实验是为了评估 circRNA 的生物功能而进行的.
- 基因和circRNA表达水平使用西部斑,qRT-PCR和IHC测试进行了分析.
- 通过双 luciferase 记者和 RNA 免疫沉 (RIP) 试验来研究分子机制.
主要成果:
- 在前列腺癌中发现了一种新型上调的circRNA,circROBO1 (hsa_circ_0124696).
- 抑制circROBO1抑制前列腺癌细胞的增殖,并增加对恩扎胺的敏感性.
- 抑制circROBO1降低了葡萄糖分解,抑制了瘤生长,克服了酶胺耐药性.
结论:
- 通过增强糖解,CircROBO1可以加速前列腺癌的生长和增强酶胺耐药性.
- 在前列腺癌中,circROBO1-miR-556-5p-PGK1轴起着重要的作用.
- CircROBO1代表了前列腺癌的潜在治疗标.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K


